• 1
    Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren [Coagulation analysis with thrombelastography, a new method]. Klin Wochenschr. 1948;26:577583.
  • 2
    Hartert H. Die thrombelastographie. Eine methode zur physikalischen analyse des blutgerinnungsvarganges [Thrombelastography, a method for physical analysis of blood coagulation]. Z Gesamte Exp Med. 1951;117:189203.
  • 3
    Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958965.
  • 4
    Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:14131425.
  • 5
    Nelson OL, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med. 2003;17:830834.
  • 6
    ROTEM Marketing Approval by FDA. Available at: Accessed July 27, 2010.
  • 7
    Jackson GN, Ashpole KJ, Yentis SM. The TEG vs the ROTEM thromboelastography/thromboelastometry systems. Anaesthesia. 2009;64:212215.
  • 8
    Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:8190.
  • 9
    Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg. 1985;64:888896.
  • 10
    Spiess BD, Gillies BS, Chandler W, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9:168173.
  • 11
    Kraft W. Das thrombelastogramm der gesunden hauskatze und die behandlung der verbrauchskoagulopathie bei panleukopenie [Thrombelastogram in healthy domestic cats and therapy of disseminated intravascular coagulation (DIC) in panleukopenia]. Berl Munch Tierarztl Wochenschr. 1973;86:394396.
  • 12
    Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J Vet Diagn Invest. 2009;21:641648.
  • 13
    Epstein KL, Brainard BM, Lopes MA, et al. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care (San Antonio). 2009;19:96101.
  • 14
    Leclere M, Lavoie JP, Dunn M, Bédard C. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses. Vet Clin Pathol. 2009;38:462466.
  • 15
    Marschner CB, Bjornvad CR, Kristensen AT, et al. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet Scand. 2010;52:3842.
  • 16
    Paltrinieri S, Meazza C, Giordano A, Tunesi C. Validation of thromboelastometry in horses. Vet Clin Pathol. 2008;37:277285.
  • 17
    Wiinberg B, Jensen AL, Rojkjaer R, Johansson P, Kjelgaard-Hansen M, Kristensen AT. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol. 2005;34:389393.
  • 18
    Kashuk JL, Moore EE, Sabel A, et al. Rapid thromboelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009;146:764772; discussion 772–764.
  • 19
    Alwood AJ, Downend AB, Brooks MB, et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med. 2007;21:378387.
  • 20
    Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thrombelastography with common coagulation tests. Thromb Haemost. 1981;46:752756.
  • 21
    Pittman JR, Koenig A, Brainard BM. The effect of unfractionated heparin on thrombelastographic analysis in healthy dogs. J Vet Emerg Crit Care (San Antonio). 2010;20:216223.
  • 22
    Bowbrick VA, Mikhailidis DP, Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets. 2003;14:219224.
  • 23
    Wiinberg B, Jensen AL, Rozanski E, et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J. 2009;179:121129.
  • 24
    Alexander DC, Butt WW, Best JD, Donath SM, Monagle PT, Shekerdemian LS. Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support. Thromb Res. 2010;125:387392.
  • 25
    Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009;67:266275; discussion 275–266.
  • 26
    Wagg CR, Boysen SR, Bedard C. Thrombelastography in dogs admitted to an intensive care unit. Vet Clin Pathol. 2009;38:453461.
  • 27
    Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol. 2009;26:358364.
  • 28
    Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009;108:751758.
  • 29
    Wiinberg B, Jensen AL, Johansson PI, Rozanski E, Tranholm M, Kristensen AT. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med. 2008;22:357365.
  • 30
    Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118:22862297.
  • 31
    Vaya A, Mira Y, Martinez M, et al. Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc. 2002;26:4153.
  • 32
    Vannucchi AM, Barbui T. Thrombocytosis and thrombosis. Hematology Am Soc Hematol Educ Program. 2007;363370.
  • 33
    Kuo YR, Yang KD, Huang MN, Wei FC, Jeng SF. Reactive thrombocytosis without endothelial damage does not affect the microvascular anastomotic patency. Ann Plast Surg. 2003;50:5763.
  • 34
    Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100:792797.
  • 35
    Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67:125131.
  • 36
    Summaria L, Sandesara J, Yang G, Vagher JP, Caprini JA. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Thromb Haemost. 1986;56:7179.
  • 37
    Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2009;20:419426.
  • 38
    Theusinger OM, Nurnberg J, Asmis LM, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg. 2010;37:677683.
  • 39
    White H, Zollinger C, Jones M, Bird R. Can thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol. 2010;32:167173.
  • 40
    Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion. 2008;48:23772383.
  • 41
    Wiinberg B, Jensen AL, Kjelgaard-Hansen M, et al. Study on biological variation of haemostatic parameters in clinically healthy dogs. Vet J. 2007;174:6268.
  • 42
    Vilar P, Couto CG, Westendorf N, Iazbik C, Charske J, Marin L. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med. 2008;22:374379.
  • 43
    Tripodi A, Cappellini MD, Chantarangkul V, et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica. 2009;94:15201527.
  • 44
    Spiezia L, Radu C, Marchioro P, et al. Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients. Thromb Haemost. 2008;100:11061110.
  • 45
    Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood. 2003;101:44164422.
  • 46
    Iselin BM, Willimann PF, Seifert B, et al. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth. 2001;87:246249.
  • 47
    Kretschmer V, Daraktchiev A, Karger R. Does haemodilution produce a hypercoagulable state? Thromb Haemost. 2004;92:670671.
  • 48
    Bauer NB, Eralp O, Moritz A. Effect of hemolysis on canine kaolin-activated thromboelastography values and ADVIA 2120 platelet activation indices. Vet Clin Pathol. 2010;39:180189.
  • 49
    Dallap Schaer BL, Bentz AI, Boston RC, Palmer JE, Wilkins PA. Coagulation testing in critically ill neonatal foals: comparison between viscoelastic analysis and standard coagulation profiles [Abstract]. J Vet Emerg Crit Care (San Antonio). 2008;18:421.
  • 50
    Mendez J, Vilar P, Mudge M, Couto CG. Thromboelastography (TEG) for early detection of hemostatic abnormalities in horses with colic [Abstract]. J Vet Intern Med. 2008;22:816.
  • 51
    Mendez JL, Vilar P, Mudge MC, Couto CG. Thromboelastography (TEG): an innovative technique for early detection of hemostatic abnormalities in foals with septicemia [Abstract]. J Vet Intern Med. 2009;23:720.
  • 52
    Van Vliet KJ, Smit GL, Pieterse JJ, Schoonbee HJ, Van Vuren JH. Thrombelastographic diagnosis of blood coagulation in two freshwater fish species. Comp Biochem Physiol A Comp Physiol. 1985;82:1921.
  • 53
    Van Vliet KJ, Smit GL, Pieterse JJ, Schoonbee HJ, Van Vuren JH. A thrombelastographic study of the effect of stress on the blood coagulation in Cyprinus carpio (Cyprinidae) and Oreochromis mossambicus (Cichlidae). Comp Biochem Physiol A Comp Physiol. 1985;82:2327.
  • 54
    Raina S, Spillert CR, Greenstein SM, Lazaro EJ. Effect of surgery on tumor-induced accelerated coagulation in a rat carcinoma. J Surg Res. 1985;38:138142.
  • 55
    Kaspareit J, Messow C, Edel J. Blood coagulation studies in guinea pigs (Cavia porcellus). Lab Anim. 1988;22:206211.
  • 56
    Moalic P, Gruel Y, Foloppe P, Delahousse B, Leclerc MH, Leroy J. Hemostasis development in the lamb fetus and neonate. Am J Vet Res. 1989;50:5963.
  • 57
    Heene D, Hoffmann-Fezer G, Muller-Berghaus G, Hoffmann R, Weiss E, Lasch HG. Gerinnungsstorungen bei akuter scheinepest [Coagulation disorders in acute hog cholera]. Beitr Pathol. 1971;144:259271.
  • 58
    Hinaidy HK. Thrombelastogramn von mit Fasciola hepatica infizierten sehafen [The thromboelastogram of sheep infected with Fasciola hepatica]. Z Parasitenkd. 1968;31:12.
  • 59
    Kotschy M. Der einfluss von prothrombin- und fibrinogen-antisera auf das gerinnungssystem von rinderblut [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood]. Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;98:426436.
  • 60
    Hardie EM, Vaden SL, Spaulding K, Malarkey DE. Splenic infarction in 16 dogs: a retrospective study. J Vet Intern Med. 1995;9:141148.
  • 61
    Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985–1995. J Vet Intern Med. 1999;13:338345.
  • 62
    Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol. 1993;30:2835.
  • 63
    Otto CM, Rieser TM, Brooks MB, Russell MW. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc. 2000;217:15001504.
  • 64
    Kristensen AT, Wiinberg B, Jessen LR, Adreasen E, Jensen AL. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med. 2008;22:140147.
  • 65
    Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000–2008). J Vet Emerg Crit Care (San Antonio). 2009;19:484488.
  • 66
    Fenty RK, DeLaforcade AM, Shaw SP, O'Toole TE. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia utilizing thromboelastography [Abstract]. J Vet Emerg Crit Care (San Antonio). 2008;18:411.
  • 67
    Kol A, Nelson RW, Borjesson DL. Dogs with hyperadrenocorticism are hypercoagulable and have prolonged PFA-100 closure times [Abstract]. Vet Clin Pathol. 2009;38(Suppl):E5.
  • 68
    Rose L, Bedrad C, Dunn M. Effect of prednisone administration on thrombelastographic parameters in healthy beagles [Abstract]. J Vet Intern Med. 2008;22:738.
  • 69
    Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110:23392346.
  • 70
    Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A. Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis. Br J Cancer. 2005;92:13491351.
  • 71
    Wada H, Sase T, Yamaguchi M. Hypercoagulant states in malignant lymphoma. Exp Oncol. 2005;27:179185.
  • 72
    Winter PC. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology. Hematol Oncol. 2006;24:126133.
  • 73
    LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986–1987). J Am Vet Med Assoc. 1990;197:13681372.
  • 74
    Pusterla S, Previtali S, Marziali S, et al. Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J. 2004;5:341346.
  • 75
    Van Zaane B, Nur E, Squizzato A, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab. 2009;94:27432750.
  • 76
    Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg. 2009;108:734742.
  • 77
    McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennet-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg. 2005;100:15761583.
  • 78
    Wilson D, Cooke EA, McNally MA, Wilson HK, Yeates A, Mollan RA. Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Injury. 2001;32:765770.
  • 79
    Bigge LA, Brown DJ, Penninck DG. Correlation between coagulation profile findings and bleeding complications after ultrasound-guided biopsies: 434 cases (1993–1996). J Am Anim Hosp Assoc. 2001;37:228233.
  • 80
    Vaden SL, Levine JF, Lees GE, Groman RP, Graver GF, Forrester SD. Renal biopsy: a retrospective study of methods and complications in 283 dogs and 65 cats. J Vet Intern Med. 2005;19:794801.
  • 81
    Prasad S, Lillicrap D, Labelle A, et al. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood. 2008;111:672679.
  • 82
    Othman M, Powell S, Chirinian Y, Hegadorn C, Hopman W, Lillicrap D. Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise. Haemophilia. 2009;15:11261134.
  • 83
    Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis. 2010;21:168174.
  • 84
    Feige K, Schwarzwald CC, Bombeli T. Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial. Equine Vet J. 2003;35:506513.
  • 85
    Scott KC, Hansen BD, DeFrancesco TC. Coagulation effects of low molecular weight heparin compared with heparin in dogs considered to be at risk for clinically significant venous thrombosis. J Vet Emerg Crit Care (San Antonio). 2009;19:7480.
  • 86
    Smith CE, Rozanski EA, Freeman LM, Brown DJ, Goodman JB, Rush JE. Use of low molecular weight heparin in cats: 57 cases (1999–2003). J Am Vet Med Assoc. 2004;225:12371241.
  • 87
    Jessen LR, Wiinberg B, Jensen AL, et al. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol. 2008;37:363372.
  • 88
    Vargo CL, Taylor SM, Carr A, Jackson ML. The effect of a low molecular weight heparin on coagulation parameters in healthy cats. Can J Vet Res. 2009;73:132136.
  • 89
    Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma. 2009;66:15091515; discussion 1515–1507.
  • 90
    Brooks MB. von Willebrand disease. In: FeldmanBF, ZinklJG, JainNC, eds. Schalm's Veterinary Hematology. 5th ed. Ames, IA: Blackwell Publishing; 2000:509515.
  • 91
    Boudreaux MK. Characteristics, diagnosis, and treatment of inherited platelet disorders in mammals. J Am Vet Med Assoc. 2008;233:12511259, 1190.
  • 92
    Boudreaux MK. Acquired platelet dysfunction. In: FeldmanBF, ZinklJG, JainNC, eds. Schalm's Veterinary Hematology. 5th ed. Ames, IA: Blackwell Publishing; 2000:496500.
  • 93
    Baek SJ, McEntee MF, Legendre AM. Review paper: cancer chemopreventive compounds and canine cancer. Vet Pathol. 2009;46:576588.
  • 94
    Papich MG. An update on nonsteroidal anti-inflammatory drugs (NSAIDs) in small animals. Vet Clin North Am Small Anim Pract. 2008;38:12431266, vi.
  • 95
    Mathews KA. Pain management for the pregnant, lactating, and neonatal to pediatric cat and dog. Vet Clin North Am Small Anim Pract. 2008;38:12911308, vi–vii.
  • 96
    Goodman L, Coles TB, Budsberg S. Leukotriene inhibition in small animal medicine. J Vet Pharmacol Ther. 2008;31:387398.
  • 97
    Lascelles BD, Court MH, Hardie EM, Robertson SA. Nonsteroidal anti-inflammatory drugs in cats: a review. Vet Anaesth Analg. 2007;34:228250.
  • 98
    Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse—a review. Vet J. 2006;171:5169.
  • 99
    Lindahl TL, Ramstrom S. Methods for evaluation of platelet function. Transfus Apher Sci. 2009;41:121125.
  • 100
    Collet JP, Montalescot G. Platelet function testing and implications for clinical practice. J Cardiovasc Pharmacol Ther. 2009;14:157169.
  • 101
    Craft RM, Chavez JJ, Bresee SJ, Worthman DC, Cohen E, Carroll RC. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med. 2004;143:301309.
  • 102
    Brooks MB, Randolph J, Warner K, Center S. Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome. Vet Clin Pathol. 2009;38:306315.
  • 103
    Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res. 2007;68:251257.
  • 104
    Brainard BM, Kleine SM, Budsberg SC. Utility of thromelastograph (TEG) plateletmapping for evaluation of clopidogrel in dogs [Abstract]. J Vet Intern Med. 2008;22:739.
  • 105
    Bochsen L, Nielsen AB, Steinbruchel DA, Johansson PI. Higher thrombelastograph platelet reactivity in cardiac surgery patients than in blood donors. Scand Cardiovasc J. 2007;41:321324.
  • 106
    Scharbert G, Auer A, Kozek-Langenecker S. Evaluation of the platelet mapping assay on rotational thromboelastometry ROTEM. Platelets. 2009;20:125130.